⌘K

Login Start Free

Home/Filings/4/0000899243-17-018643

4//SEC Filing

MADDEN DAVID 4

Accession 0000899243-17-018643

CIK 0001399529other

View on SEC.gov Company Profile

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 5:00 PM ET

Size

5.3 KB

Accession

0000899243-17-018643

Insider Transaction Report

Form 4

Period: 2017-07-18

Dicerna Pharmaceuticals IncDRNA

Director

Transactions

Award
Director Stock Option (right to buy)
2017-07-18+33,000→ 33,000 total
Exercise: $3.42Exp: 2027-07-18→ Common Stock (33,000 underlying)

Footnotes (1)

[F1]This option vests monthly over 12 months from July 11, 2017 in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeother

Related Parties

1

filerCIK 0001230836

Filing Metadata

Form type: 4
Filed: Jul 19, 8:00 PM ET
Accepted: Jul 20, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov